Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy

British Journal of Cancer

Volumn 110, Issue 2, 2014, Pages 297-303

  Tian, Y M ^a   Tian, Y H ^b,c   Zeng, L ^a   Liu, S ^a   Guan, Y ^a   Lu, T X ^a   Han, F ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c Guangdong Armed Police Hospital   (China)

Author keywords

intensity modulated radiotherapy (IMRT); late complications; local recurrence; nasopharyngeal carcinoma; prognostic score model

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BRAIN DISEASE; BRAIN INFECTION; CANCER PROGNOSIS; CANCER SURVIVAL; CAUSE OF DEATH; CRANIAL NEUROPATHY; DISEASE FREE INTERVAL; DISTANT FAILURE FREE SURVIVAL; FEMALE; GASTROINTESTINAL DISEASE; HEARING IMPAIRMENT; HEART DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KARNOFSKY PERFORMANCE STATUS; LEUKEMIA; LOCAL FAILURE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL; MUCOSA INFLAMMATION; MUCOSAL NECROSIS; NASOPHARYNX CARCINOMA; OTITIS MEDIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSTIC SCORE MODEL; RADIATION INJURY; RETROSPECTIVE STUDY; TRISMUS; XEROSTOMIA; YOUNG ADULT; AGE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; LYMPH NODE METASTASIS; RADIATION DOSE; RETREATMENT; RISK ASSESSMENT; RISK FACTOR; SALVAGE THERAPY; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

CISPLATIN;

EID: 84892908959     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.715     Document Type: Article

References (28)

1. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16: 1310-1317.
2. Chow E, Payne D, O'Sullivan B, Pintilie M, Liu FF, Waldron J, Warde P, Cummings B (2002) Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study Is combined modality treatment really necessary? Radiother Oncol 63: 269-274.
3. Chua DT, Sham JS, Hung KN, Leung LH, Au GK (2006) Predictive factors of tumor control and survival after radiosurgery for local failures of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66: 1415-1421.
4. Chua DT, Sham JS, Leung LH, Au GK (2005) Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol 77: 290-294.
5. Corry J, Fisher R, Rischin D, Peters LJ (2006) Relapse patterns in WHO 2/3 nasopharyngeal cancer: is there a difference between ethnic Asian vs non-Asian patients? Int J Radiat Oncol Biol Phys 64: 63-71.
6. Han F, Zhao C, Huang SM, Lu LX, Huang Y, Deng XW, Mai WY, Teh BS, Butler EB, Lu TX (2012) Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) 24: 569-576.
7. Hsiung CY, Yorke ED, Chui CS, Hunt MA, Ling CC, Huang EY, Wang CJ, Chen HC, Yeh SA, Hsu HC, Amols HI (2002) Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 53: 638-647.
8. Hsu MM, Hong RL, Ting LL, Ko JY, Sheen TS, Lou PJ (2001) Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: experience with 60 cases. Arch Otolaryngol Head Neck Surg 127: 798-802.
9. Hua YJ, Chen MY, Qian CN, Hong MH, Zhao C, Guo L, Guo X, Cao KJ (2009) Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma. Head Neck 31: 807-812.
10. Hua YJ, Han F, Lu LX, Mai HQ, Guo X, Hong MH, Lu TX, Zhao C (2012) Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. Eur J Cancer 48: 3422-3428.
11. Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT (2004) Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60: 1440-1450.
12. Law SC, Lam WK, Ng MF, Au SK, Mak WT, Lau WH (2002) Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage. Int J Radiat Oncol Biol Phys 54: 1095-1113.
13. Lee AW, Foo W, Law SC, Peters LJ, Poon YF, Chappell R, Sze WM, Tung SY, Lau WH, Ho JH (2000) Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 46: 865-872.
14. Lee AW, Law SC, Foo W, Poon YF, Cheung FK, Chan DK, Tung SY, Thaw M, Ho JH (1993) Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence. Int J Radiat Oncol Biol Phys 26: 773-782.
15. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY, Kwong DL, Lau WH (2005) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61: 1107-1116.
16. Lu TX, MaiWY, Teh BS, Zhao C, Han F,Huang Y, Deng XW, Lu LX, Huang SM, Zeng ZF, Lin CG, Lu HH, Chiu JK, Carpenter LS, Grant WR, Woo SY, Cui NJ, Butler EB (2004) Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 58: 682-687.
17. Marx RE (1983) Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 41: 283-288.
18. Oksuz DC, Meral G, Uzel O, Cagatay P, Turkan S (2004) Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 60: 388-394.
19. Pignon JP, le Maitre A, Maillard E, Bourhis J (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17 346 patients. Radiother Oncol 92: 4-14.
20. Qiu S, Lin S, Tham IW, Pan J, Lu J, Lu JJ (2012) Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 83: 676-683.
21. Roeder F, Zwicker F, Saleh-Ebrahimi L, Timke C, Thieke C, Bischof M, Debus J, Huber PE (2011) Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer. Radiat Oncol 6: 22.
22. Teo PM, Kwan WH, Chan AT, Lee WY, King WW, Mok CO (1998) How successful is high-dose (4 or60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 40: 897-913.
23. Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET, Yang E, Lee KM, Fong KW, Tan HS, Lee KS, Loong S, Sethi V, Chua EJ, Machin D (2005) Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23: 6730-6738.
24. Wei WI (2000) Salvage surgery for recurrent primary nasopharyngeal carcinoma. Crit Rev Oncol Hematol 33: 91-98.
25. Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. Lancet 365: 2041-2054.
26. Yu KH, Leung SF, Tung SY, Zee B, Chua DT, Sze WM, Law SC, Kam MK, Leung TW, Sham JS, Lee AW, Au JS, Hui EP, Sze WK, Cheng AC, Yau TK, Ngan RK, Wong FC, Au GK, Chan AT (2005) Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck 27: 397-405.
27. Yu MC, Yuan JM (2002) Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12: 421-429.
28. Zheng XK, Ma J, Chen LH, Xia YF, Shi YS (2005) Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma. Radiother Oncol 75: 197-203.